SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: John O'Neill who wrote (17440)3/14/1998 12:01:00 PM
From: Andreas Helke  Respond to of 32384
 
If you want to see a biotech stock where the great future ia already in the stock price take a look at Sepracor (SEPR). In my opinion Ligand at $16 is still selling at a serious discount to its true value. That alone of course does not prevent the stock from going to a even bigger discount. But it considerably limits the risk of holding the stock for long term investors.

Andreas



To: John O'Neill who wrote (17440)3/14/1998 11:07:00 PM
From: synchro  Respond to of 32384
 
One way to look at biotech stocks is that they are really long-term LEAP call options w/ a distant expiration date (the date when the cash finally burn off to zilch). In other words, like options, they are wasting assets until they go "in the money"--when FDA approves marketing of their chemical concoctions.

As such, it's prolly wise not to choke on too much of this stuff.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News